Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 65.84 M

Lifecome Biochemistry Co.,Ltd. Net Cash Used Provided By Financing Activities is USD 65.84 M for the year ending December 31, 2023, a 542.07% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Lifecome Biochemistry Co.,Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 10.25 M, a -70.89% change year over year.
Lifecome Biochemistry Co.,Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 35.23 M, a 342.69% change year over year.
Lifecome Biochemistry Co.,Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -14.52 M, a -207.13% change year over year.
Lifecome Biochemistry Co.,Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 13.55 M, a 403.68% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years